IP Library Granted Patent US 11,920,164
Granted Patent B2
US 11,920,164 · App. 15/500,163 · Granted Mar 5, 2024

Media for culturing naive human pluripotent stem cells

Inventors: Yaqub Hanna (Tel-Aviv, IL); Noa Novershtern (Rehovot, IL); Yoach Rais (Rehovot, IL)
Assignee: Yeda Research and Development Co. Ltd.
C12N5/0696C12N5/0037C12N5/0606C12N2500/38C12N2500/90C12N2501/01C12N2501/115C12N2501/125C12N2501/15C12N2501/155C12N2501/16C12N2501/235C12N2501/415C12N2501/50C12N2501/60C12N2501/71C12N2501/72C12N2501/727C12N2501/73C12N2501/999C12N2506/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,920,164
App. No.
15/500,163
Granted
Mar 5, 2024
Kind
B2
Abstract

A culture medium is disclosed which comprises STAT3 activator, an ERK1/2 inhibitor and an Axin stabilizer, and optionally also a PKC inhibitor. Cell cultures comprising same and uses thereof are also disclosed.

Claims (6)

1. A cell culture comprising naïve human pluripotent stem cells (PSC) and a culture medium comprising about 1-300 ng/ml of LIF, about 0.05-5 μM of BIRB796, about 0.1-5 μM of CHIR99021, about 0.1-50 μM of PD032590, about 0.5-25 μM of SP600125, about 0.1-25 μM of Y27632, about 0.2-10 μM of CGP77675, about 0.1-20 ng/ml of TGFβ1 and about 0.5-10 μM of IWR1, and

wherein the culture medium is capable of maintaining the human naive PSC in a naive state for at least 5 passages, and wherein

(i) when said naive PSC is a female PSC, then said naive female PSC has two unmethylated alleles of the promoter of the X-inactive specific transcript (XIST) gene; and

(ii) when said naive PSC is a male PSC, then said naive male PSC has an unmethylated allele of said promoter of said XIST gene, and

said naive state is characterized by: ability to maintain pluripotency the absence of DNA methyltransferase 1 (DNMT1) expression as determined by OCT4 expression in an immunostaining assay; and

an expression level of transcription factor E3 (TFE3) in said naive PSC is characterized by a nucleus to cytoplasm expression ratio which is equal to or higher than 1 as determined by an immunostaining assay.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 8, 2017
From: HANNA, YAQUB; NOVERSHTERN, NOA; RAIS, YOACH
To: YEDA RESEARCH AND DEVELOPMENT CO. LTD.
Reel/Frame 041199/0526 →
Continuity (3)
Provisional Application 62167469 · May 28, 2015
Provisional Application 62030792 · Jul 30, 2014
Related Publication 20170275593A1 · Sep 28, 2017